UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination

PLoS pathogens, 2012-05, Vol.8 (5), p.e1002704-e1002704

2012

Volltextzugriff (PDF)

Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells

PLoS pathogens, 2010-08, Vol.6 (8), p.e1001063

2010

Volltextzugriff (PDF)

Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL

PLoS pathogens, 2022-04, Vol.18 (4), p.e1010206-e1010206

2022

Volltextzugriff (PDF)

Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells

PLoS pathogens, 2015-06, Vol.11 (6), p.e1004906-e1004906

2015

Volltextzugriff (PDF)

RNAs in Epstein–Barr virions control early steps of infection

Proceedings of the National Academy of Sciences - PNAS, 2012-05, Vol.109 (21), p.E1396-E1404

2012

Volltextzugriff (PDF)

Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complex

Nature communications, 2024-01, Vol.15 (1), p.414-414, Article 414

2024

Volltextzugriff (PDF)

CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients

PloS one, 2022-05, Vol.17 (5), p.e0268530-e0268530

2022

Volltextzugriff (PDF)

Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

Proceedings of the National Academy of Sciences - PNAS, 2008-11, Vol.105 (45), p.17481-17486

2008

Volltextzugriff (PDF)

A central role of IKK2 and TPL2 in JNK activation and viral B-cell transformation

Nature communications, 2020-02, Vol.11 (1), p.685-16, Article 685

2020

Volltextzugriff (PDF)

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages

Frontiers in immunology, 2022-10, Vol.13, p.929339-929339

2022

Volltextzugriff (PDF)

Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion

PLoS pathogens, 2013-05, Vol.9 (5), p.e1003383-e1003383

2013

Volltextzugriff (PDF)

Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity

Frontiers in immunology, 2022-09, Vol.13, p.889836-889836

2022

Volltextzugriff (PDF)

Characterization and clinical enrichment of HLA-C07:02-restricted Cytomegalovirus-specific CD8+ T cells

PloS one, 2018-02, Vol.13 (2), p.e0193554-e0193554

2018

Volltextzugriff (PDF)

Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts

Journal of translational medicine, 2018-05, Vol.16 (1), p.124-124, Article 124

2018

Volltextzugriff (PDF)

Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B

PLoS pathogens, 2018-04, Vol.14 (4), p.e1006991-e1006991

2018

Volltextzugriff (PDF)

Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings

Annals of hematology, 2015-10, Vol.94 (10), p.1677-1688

2015

Volltextzugriff (PDF)

Conditional immortalization of human B cells by CD40 ligation

PloS one, 2008-01, Vol.3 (1), p.e1464-e1464

2008

Volltextzugriff (PDF)

Toll-Like Receptor Agonists Synergistically Increase Proliferation and Activation of B Cells by Epstein-Barr Virus

Journal of Virology, 2010-04, Vol.84 (7), p.3612-3623

2010

Volltextzugriff (PDF)

Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation

Journal of clinical virology, 2016-09, Vol.82, p.33-40

2016

Volltextzugriff (PDF)

Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial

Clinical & translational immunology, 2020, Vol.9 (3), p.e1117-n/a

2020

Volltextzugriff (PDF)

Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy

PloS one, 2007-07, Vol.2 (7), p.e583-e583

2007

Volltextzugriff (PDF)

Antigen-Specific TCR Signatures of Cytomegalovirus Infection

The Journal of immunology (1950), 2019-02, Vol.202 (3), p.979-990

2019

Volltextzugriff (PDF)

Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8⁺ T cells

Proceedings of the National Academy of Sciences - PNAS, 2016-10, Vol.113 (42), p.E6467-E6475

2016

Volltextzugriff (PDF)

Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing

The Journal of experimental medicine, 2016-09, Vol.213 (10), p.2065-2080

2016

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Englisch
(110)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(82)
Life Sciences & Biomedicine
(64)
Humans
(59)
Immunology
(28)
Epstein-Barr Virus
(19)
Cd8-Positive T-Lymphocytes - Immunology
(18)
Male
(18)
Female
(17)
Lymphocytes
(16)
Oncology
(15)
Cytomegalovirus
(14)
Adult
(13)
Lymphocytes T
(13)
Infections
(12)
Middle Aged
(12)
Multidisciplinary Sciences
(12)
Proteins
(12)
Science & Technology - Other Topics
(12)
Antigens
(11)
Antigens, Viral - Immunology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination

Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells

Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL

Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells

RNAs in Epstein–Barr virions control early steps of infection

Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complex

CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients

Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

A central role of IKK2 and TPL2 in JNK activation and viral B-cell transformation

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages

Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion

Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity

Characterization and clinical enrichment of HLA-C07:02-restricted Cytomegalovirus-specific CD8+ T cells

Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts

Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B

Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings

Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Conditional immortalization of human B cells by CD40 ligation

Toll-Like Receptor Agonists Synergistically Increase Proliferation and Activation of B Cells by Epstein-Barr Virus

Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation

Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial

Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy

Antigen-Specific TCR Signatures of Cytomegalovirus Infection

Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8⁺ T cells

Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing

Suchergebnisse filtern